Post-market surveillanceGLP-1
Compound 61545
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061545
Risk Class
LOW
Last Audit
Apr 2, 2108
Research Abstract
GLP-1 candidate engineered for metabolic regulation initiatives with automated dossier coverage.
Compound 61545 is a glp-1 asset inside glp-1 innovation track initiatives, optimized for metabolic regulation and cardiometabolic recovery.
The dossier currently sits in post-market surveillance with a low risk rating, meaning it is cleared for baseline monitoring protocols.
Supply records cite CAS AUTO-061545 with updates logged 2108-04-02.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Metabolic regulationCardiometabolic recovery
Nomenclature
CX-61545GLP-1 Program 61545
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061545
- [2] Operations Pulse • GLP-1 innovation track
- [3] Risk Governance Ledger • LOW clearance for COMPOUND-61545